Haleon plc (HLN) shareholders
Close on Nov 17, 2026Market cap $40.51BP/E 18.5Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 745,718,619 | 8.50% | 13G (passive) amendment | Jun 30, 2026 |
| Wellington Management Group LLP Joint filing with Wellington Group Holdings LLP (5.00%), Wellington Investment Advisors Holdings LLP (5.00%) | 443,046,686 | 5.00% | 13G (passive) amendment | Dec 31, 2025 |
| Dodge & Cox | 233,276,589 | 6.50% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HLN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dodge & Cox | 149,934,507 | – | $1.40B | +3,394,844 | 0.73% |
| FMR LLC | 120,991,250 | – | $1.13B | +7,022,091 | 0.05% |
| Clearbridge Investments, LLC | 32,342,126 | – | $301.75M | +623,401 | 0.25% |
| Morgan Stanley | 19,461,762 | – | $181.58M | +295,509 | 0.01% |
| Harris Associates L P | 16,833,252 | – | $157.05M | +1,801,211 | 0.21% |
| Harding Loevner LP | 15,414,796 | – | $147.82M | −297,754 | 1.39% |
| Nuveen, LLC | 15,332,859 | – | $143.06M | +6,633,766 | 0.03% |
| Arrowstreet Capital, Limited Partnership | 14,181,817 | – | $132.32M | −492,701 | 0.06% |
| Bank Of America Corp /De/ | 10,850,097 | – | $101.23M | −84,131 | 0.01% |
| JPMorgan Chase & Co | 10,824,395 | – | $100.99M | +2,544,927 | 0.01% |
| Point72 Asset Management, L.P. | 9,264,255 | – | $86.44M | +2,690,217 | 0.10% |
| First Eagle Investment Management, LLC | 8,449,712 | – | $78.84M | +4,417,069 | 0.07% |
| Raymond James Financial Inc | 7,278,875 | – | $67.91M | +1,014,834 | 0.02% |
| Norges Bank | 7,175,000 | – | $66.94M | New | 0.01% |
| Jones Financial Companies Lllp | 7,116,095 | – | $65.75M | −1,970,433 | 0.03% |
| Aristotle Capital Management, LLC | 7,090,436 | – | $66.15M | −573,078 | 0.14% |
| Douglas Lane & Associates, LLC | 6,692,390 | – | $62.44M | −1,393 | 0.85% |
| Natixis Advisors, L.P. | 6,652,349 | – | $62.07M | −2,545,950 | 0.07% |
| Envestnet Asset Management Inc | 6,276,154 | – | $58.56M | −758,624 | 0.01% |
| Goldman Sachs Group Inc | 5,394,442 | – | $50.33M | −733,010 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 639 | 596M | 86 / 212 | 214 / 57 | 61M | 33M |
| Q1 2026 | 625 | 568M | 88 / 214 | 178 / 65 | 67M | 65M |
| Q4 2025 | 609 | 566M | 92 / 229 | 155 / 70 | 74M | 66M |
| Q3 2025 | 600 | 562M | 69 / 161 | 240 / 88 | 39M | 58M |
| Q2 2025 | 627 | 581M | 85 / 219 | 174 / 48 | 59M | 48M |
| Q1 2025 | 599 | 570M | 54 / 192 | 206 / 55 | 58M | 217M |
| Q4 2024 | 610 | 734M | 99 / 201 | 175 / 68 | 249M | 31M |
| Q3 2024 | 588 | 521M | 71 / 181 | 198 / 55 | 23M | 24M |
| Q2 2024 | 581 | 524M | 57 / 217 | 180 / 65 | 65M | 65M |
| Q1 2024 | 598 | 524M | 72 / 199 | 182 / 54 | 159M | 35M |
| Q4 2023 | 591 | 401M | 91 / 180 | 187 / 60 | 38M | 28M |
| Q3 2023 | 569 | 391M | 61 / 179 | 177 / 62 | 41M | 27M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
74 funds held HLN in Q2 2026, 3% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of HLN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 107,251,461 | – | $1.00B | 0.85% | Jun 30, 2026 |
| Fidelity Series Large Cap Stock Fund | 18,874,236 | – | $176.10M | 0.61% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 14,710,159 | – | $133.27M | 0.05% | May 31, 2026 |
| Oakmark International Fund | 13,300,500 | – | $124.09M | 1.00% | Jun 30, 2026 |
| Fidelity Growth and Income Portfolio | 12,004,220 | – | $118.48M | 0.80% | Jul 31, 2026 |
| Dodge & Cox Balanced Fund | 11,685,813 | – | $109.03M | 0.74% | Jun 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 9,218,243 | – | $86.01M | 0.06% | Jun 30, 2026 |
| Fidelity Large Cap Stock Fund | 6,840,625 | – | $67.52M | 0.64% | Jul 31, 2026 |
| Bridge Builder Large Cap Value Fund | 4,975,893 | – | $46.43M | 0.16% | Jun 30, 2026 |
| Fidelity Advisor Capital Development Fund | 4,150,000 | – | $38.72M | 0.61% | Jun 30, 2026 |
| Fidelity Mega Cap Stock Fund | 3,960,733 | – | $36.95M | 0.53% | Jun 30, 2026 |
| ClearBridge Large Cap Value Fund | 3,117,021 | – | $30.76M | 1.27% | Jul 31, 2026 |
| VanEck Pharmaceutical ETF | 2,913,351 | – | $27.18M | 3.09% | Jun 30, 2026 |
| Nuveen Multi Cap Value Fund | 2,733,619 | – | $25.50M | 2.03% | Jun 30, 2026 |
| VIP Growth and Income Portfolio | 2,243,094 | – | $20.93M | 0.73% | Jun 30, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Haleon's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,295,391 shares on Sep 22, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| GlaxoSmithKline (US) Trust Affiliate | Dec 29, 2023 | 8,527,104 | $70.60M | Dec 27, 2023 | The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc |
| GSK Master Grantor Trust Affiliate | Dec 5, 2023 | 404,599 | $3.47M | Dec 5, 2023 | The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc |
| GlaxoSmithKline Employee Trust Affiliate | Nov 3, 2023 | 173,611 | $1.38M | Nov 6, 2023 | The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc |
See a number that looks wrong?